Vivos Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Vivos Therapeutics, Inc. (VVOS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 500.00 thousand shares for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-06-08.
Discontinued › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2023-06-08
- Vivos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2023-03-31 was 500.00K shares, a 146.31% increase year-over-year.
- Vivos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2022-12-31 was 683.00K shares, a 3315.00% increase year-over-year.
- Vivos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2022-09-30 was 290.00K shares.
- Vivos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2022-06-30 was 30.00K shares.
- Vivos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 1.21M shares, a 448.18% increase from fiscal 2021.
- Vivos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2021 was 220.00K shares, a 714.81% increase from fiscal 2020.
- Vivos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2020 was 27.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2023-03-31 | 500.00K shares 10-Q · filed 2023-06-08 | 1.18M shares derived: sum of 2 quarters · filed 2023-06-08 | 1.47M shares derived: sum of 3 quarters · filed 2023-06-08 | 1.50M shares derived: sum of 4 quarters · filed 2023-06-08 |
| 2022-12-31 | 683.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 973.00K shares derived: sum of 2 quarters · filed 2023-03-30 | 1.00M shares derived: sum of 3 quarters · filed 2023-03-30 | 1.21M shares 10-K · filed 2023-03-30 |
| 2022-09-30 | 290.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-12-20 | 320.00K shares derived: sum of 2 quarters · filed 2022-12-20 | 523.00K shares 10-Q · filed 2022-12-20 | 543.00K shares derived: sum of 4 quarters · filed 2023-03-30 |
| 2022-06-30 | 30.00K shares derived: 10-Q 6 month − 10-Q/A 3 month · filed 2022-12-20 | 233.00K shares 10-Q · filed 2022-12-20 | 253.00K shares derived: sum of 3 quarters · filed 2023-03-30 | |
| 2022-03-31 | 203.00K shares 10-Q/A · filed 2022-11-25 | 223.00K shares derived: sum of 2 quarters · filed 2023-03-30 | ||
| 2021-12-31 | 20.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 220.00K shares 10-K · filed 2023-03-30 | ||
| 2021-09-30 | 200.00K shares 10-Q · filed 2022-12-20 | |||
| 2020-12-31 | 27.00K shares 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |